Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.989 USD | +2.67% | -15.59% | -29.04% |
Mar. 27 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
Mar. 27 | Wedbush Adjusts bluebird bio's PT to $1.72 From $1.68, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.04% | 186M | |
-3.58% | 102B | |
+2.01% | 96.84B | |
-0.82% | 21.48B | |
-18.27% | 20.82B | |
-7.40% | 18.6B | |
-40.70% | 16.81B | |
-26.44% | 13.78B | |
+0.84% | 13.4B | |
+21.78% | 11.06B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- bluebird bio : BMO Capital Adjusts Bluebird Bio's Price Target to $35 From $31, Maintains Market Perform Rating